Observe Medical ASA: Mandatory notification of trade by primary insider

22 Oct 2025 15:27 CEST

Oslo, 22 October 2025: Observe Medical ASA (the "Company") has been informed
that Jørgen Mann, CEO and primary insider in the Company, has today purchased
30,000 shares in the Company as further specified in the attached notification
form.

Following the purchase, Jørgen Mann holds 870,000 shares in the Company.

This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

657721_OMASA_PDMR_appendix_JM2210.pdf